Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. 1998

N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
Laboratory of Medical Virology, The Rockefeller University, New York, NY 10021, USA.

To investigate the diversity of the T cell repertoire involved in human T lymphotropic virus type I (HTLV-I) infections, peripheral blood T cell subsets were analyzed by using a PCR-based assay that permits determination of complementarity-determining region 3 (CDR3) length variation in TCR Vbeta transcripts. In two of four asymptomatic HTLV-I carriers and in four of five patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), mono- or oligoclonal expansions were detected in the CD4+ T cell subset. In one patient with adult T cell leukemia, a specific clone bearing Vbeta7 was detected in the CD4+ T cell subset. In contrast, clonal expansion was not observed in the CD4 T cell subsets of three individuals with asymptomatic HTLV-II infection or in our previous studies of a large number of uninfected individuals. Oligoclonal expansions in the CD8+ T cell subset were detected in all subjects, including the patient with adult T cell leukemia. No differences in the number of expanded clones were noted between asymptomatic carriers and in patients with HAM/TSP and there was no obvious restriction in the TCR V region usage. Direct sequencing revealed no significant bias in the CDR3 motifs utilized by the predominant clones. This report is the first direct demonstration of clonal expansions within fractionated T cell subsets (CD4+ and CD8+) in HTLV-I infections and suggests that 1) clonal expansion of CD4+ T lymphocytes likely occurs as a direct result of infection and 2) polyclonal CD8+ T cell expansion occurs frequently and independently of disease association.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D005260 Female Females
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015329 Gene Rearrangement, T-Lymphocyte Ordered rearrangement of T-cell variable gene regions coding for the antigen receptors. Gene Rearrangement, T-Cell Antigen Receptor,T-Cell Gene Rearrangement,T-Lymphocyte Gene Rearrangement,Gene Rearrangement, T-Cell,Gene Rearrangement, T Cell,Gene Rearrangement, T Cell Antigen Receptor,Gene Rearrangement, T Lymphocyte,Gene Rearrangements, T-Cell,Gene Rearrangements, T-Lymphocyte,Rearrangement, T-Cell Gene,Rearrangement, T-Lymphocyte Gene,Rearrangements, T-Cell Gene,Rearrangements, T-Lymphocyte Gene,T Cell Gene Rearrangement,T Lymphocyte Gene Rearrangement,T-Cell Gene Rearrangements,T-Lymphocyte Gene Rearrangements

Related Publications

N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
February 1997, Journal of immunology (Baltimore, Md. : 1950),
N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
November 2000, Immunity,
N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
September 2014, International journal of dermatology,
N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
November 1997, Cancer research,
N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
November 1994, The Journal of clinical investigation,
N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
June 1990, Infection control and hospital epidemiology,
N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
September 1995, The Journal of infectious diseases,
N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
June 2009, Biomedica : revista del Instituto Nacional de Salud,
N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
May 1991, Journal of clinical immunology,
N Eiraku, and R Hingorani, and S Ijichi, and K Machigashira, and P K Gregersen, and J Monteiro, and K Usuku, and S Yashiki, and S Sonoda, and M Osame, and W W Hall
September 2001, Blood,
Copied contents to your clipboard!